Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 9651320, 10 pages
https://doi.org/10.1155/2018/9651320
Research Article

The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis

Tumor Etiology and Screening Department, Cancer Institute and General Surgery, The First Hospital of China Medical University and Key Laboratory of Cancer Etiology and Prevention, Liaoning Provincial Education Department, China Medical University, Shenyang 110001, China

Correspondence should be addressed to Yuan Yuan; nc.ude.umc@nauynauy and Chengzhong Xing; moc.621@6691zcx

Received 19 October 2017; Revised 12 December 2017; Accepted 14 December 2017; Published 15 January 2018

Academic Editor: Paul W. Doetsch

Copyright © 2018 Jingwei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. H. Schreuders, A. Ruco, L. Rabeneck et al., “Colorectal cancer screening: a global overview of existing programmes,” Gut, vol. 64, no. 10, pp. 1637–1649, 2015. View at Publisher · View at Google Scholar
  2. L. Zhang and J. W. Shay, “Multiple roles of APC and its therapeutic implications in colorectal cancer,” Journal of the National Cancer Institute, vol. 109, no. 8, 2017. View at Publisher · View at Google Scholar
  3. A. Walther, E. Johnstone, C. Swanton, R. Midgley, I. Tomlinson, and D. Kerr, “Genetic prognostic and predictive markers in colorectal cancer,” Nature Reviews Cancer, vol. 9, no. 7, pp. 489–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Russo, V. Bazan, B. Iacopetta, D. Kerr, T. Soussi, and N. Gebbia, “The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment,” Journal of Clinical Oncology, vol. 23, no. 30, pp. 7518–7528, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Peters, S. Bien, and N. Zubair, “Genetic architecture of colorectal cancer,” Gut, vol. 64, no. 10, pp. 1623–1636, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. W. P. Roos, A. D. Thomas, and B. Kaina, “DNA damage and the balance between survival and death in cancer biology,” Nature Reviews Cancer, vol. 16, no. 1, pp. 20–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Nouspikel, “DNA repair in mammalian cells: Nucleotide excision repair: variations on versatility,” Cellular and Molecular Life Sciences, vol. 66, no. 6, pp. 994–1009, 2009. View at Google Scholar
  8. I. Kamileri, I. Karakasilioti, and G. A. Garinis, “Nucleotide excision repair: new tricks with old bricks,” Trends in Genetics, vol. 28, no. 11, pp. 566–573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Compe and J.-M. Egly, “Nucleotide Excision Repair and Transcriptional Regulation: TFIIH and beyond,” Annual Review of Biochemistry, vol. 85, pp. 265–290, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. L. C. J. Gillet and O. D. Schärer, “Molecular mechanisms of mammalian global genome nucleotide excision repair,” Chemical Reviews, vol. 106, no. 2, pp. 253–276, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. C. Shuck, E. A. Short, and J. J. Turchi, “Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology,” Cell Research, vol. 18, no. 1, pp. 64–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Hoeijmakers, “Genome maintenance mechanisms for preventing cancer,” Nature, vol. 411, no. 6835, pp. 366–374, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Kabzinski, K. Przybylowska, L. Dziki, A. Dziki, and I. Majsterek, “An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population,” Cancer Biomarkers, vol. 15, no. 4, pp. 413–423, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. J. Kap, O. Popanda, and J. Chang-Claude, “Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients,” Pharmacogenomics, vol. 17, no. 7, pp. 755–794, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Moreno, F. Gemignani, S. Landi et al., “Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer,” Clinical Cancer Research, vol. 12, no. 7, pp. 2101–2108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Paszkowska-Szczur, R. J. Scott, B. Górski et al., “Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population,” Molecular Biology Reports, vol. 42, no. 3, pp. 755–764, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. D. R. Rhodes, J. Yu, K. Shanker et al., “ONCOMINE: a cancer microarray database and integrated data-mining platform,” Neoplasia, vol. 6, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Cancer Genome Atlas Network, “Comprehensive molecular portraits of human breast tumours,” Nature, vol. 490, no. 7418, pp. 61–70, 2012. View at Google Scholar
  19. J. Sabates-Bellver, L. G. Van der Flier, and M. de Palo, “Transcriptome profile of human colorectal adenomas,” Molecular Cancer Research, vol. 5, no. 12, pp. 1263–1275, 2007. View at Publisher · View at Google Scholar
  20. W. L. de Laat, N. G. J. Jaspers, and J. H. J. Hoeijmakers, “Molecular mechanism of nucleotide excision repair,” Genes & Development, vol. 13, no. 7, pp. 768–785, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Enzlin and O. D. Scharer, “The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif,” EMBO Journal, vol. 21, no. 8, pp. 2045–2053, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. A. O'Donovan, A. A. Davies, J. G. Moggs, S. C. West, and R. D. Wood, “XPG endonuclease makes the 3 Incision in human DNA nucleotide excision repair,” Nature, vol. 371, no. 6496, pp. 432–435, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Leibeling, P. Laspe, and S. Emmert, “Nucleotide excision repair and cancer,” Journal of Molecular Histology, vol. 37, no. 5–7, pp. 225–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Payne and G. Chu, “Xeroderma pigmentosum group E binding factor recognizes a broad spectrum of DNA damage,” Mutation Research Regular Papers, vol. 310, no. 1, pp. 89–102, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Jens and N. Rajewsky, “Competition between target sites of regulators shapes post-transcriptional gene regulation,” Nature Reviews Genetics, vol. 16, no. 2, pp. 113–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. Q.-H. Xie, X.-X. He, Y. Chang et al., “MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells,” Biochemical and Biophysical Research Communications, vol. 410, no. 3, pp. 440–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Yu, M. A. Mallon, W. Zhang et al., “DNA repair pathway profiling and microsatellite instability in colorectal cancer,” Clinical Cancer Research, vol. 12, no. 17, pp. 5104–5111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Roy, P. V. Bommi, U. G. Bhat et al., “DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer,” Cancer Research, vol. 73, no. 12, pp. 3771–3782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Dong, J. W. Liu, Y. J. Gao, T. Zhou, and Y. M. Chen, “Relationship between DNA repair gene XPD751 single-nucleotide polymorphisms and prognosis of colorectal cancer,” Genetics and Molecular Research, vol. 14, no. 2, pp. 5390–5398, 2015. View at Publisher · View at Google Scholar
  30. M. Y. Huang, W. Y. Fang, S. C. Lee et al., “ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study,” BMC Cancer, vol. 8, p. 50, 2008. View at Google Scholar
  31. M. Ni, W.-Z. Zhang, J.-R. Qiu et al., “Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population,” Scientific Reports, vol. 4, article 4112, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M.-Y. Huang, H.-L. Tsai, C.-H. Lin et al., “Predictive value of ERCC1, ERCC2, and XRCC1 overexpression for stage III colorectal cancer patients receiving FOLFOX-4 adjuvant chemotherapy,” Journal of Surgical Oncology, vol. 108, no. 7, pp. 457–464, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. B. Kassem, S. E. Salem, M. E. Abdelrahim et al., “ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt,” Experimental and Molecular Pathology, vol. 102, no. 1, pp. 78–85, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Chatzinikolaou, Z. Apostolou, T. Aid-Pavlidis et al., “ERCC1-XPF cooperates with CTCF and cohesin to facilitate the developmental silencing of imprinted genes,” Nature Cell Biology, vol. 19, no. 5, pp. 421–432, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Kamileri, I. Karakasilioti, A. Sideri et al., “Defective transcription initiation causes postnatal growth failure in a mouse model of nucleotide excision repair (NER) progeria,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 109, no. 8, pp. 2995–3000, 2012. View at Publisher · View at Google Scholar · View at Scopus